OPA1 and cancer: Secondly, the high expression of OPA1 promotes mitochondrial function, which may also affect endocrine levels and different tissues have different responses to changes in hormone levels, such as the breast, prostate, testis, ovary, and other tissues are more sensitive to changes in hormone levels, and are more likely to cause cancer due to endocrine interference [21–23].